FDA Investigator Amy C Amaro

Amy C Amaro has conducted inspections on 42 sites in 1 countries as of 07 Nov 2017. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
42
Last Inspection Date:
07 Nov 2017
Investigator Role:
FDA Investigator
Redica ID:
100007467
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Amy C Amaro:
Ali Akbar, Amos C Epps, Amy A Johnson, Ana P Barido, Andria L Kuhlman, Armando Chavez, MS, Barbara A Burke, Barbara A Gullick, Barbara J Holladay, Beatrice Greenberg, Billingsley, Brandon L Mariner, Brian R Yaun, Bruce E Kummer, Bryan J Love, Bryce A May, Carrie L Doupnik, Charlean R Butler, Charles D Boison, Charlotte E Wilkins, Christopher R Richardson, Conrad M Guardia, David L Chon, Decima L Washington, Dennis L Doupnik, Dianne H Milazzo, Douglas A Campbell, Elizabeth A Laudig, Emily S Mcgann, Emmanuel A Dimaano, Jr, Erik T Nagaoka, Esaw, Gail L Katz, Gerald D Bromley, Jr, Gerald Mierle, Gifford Whitehurst, Jr, James W Leonette, Jesse P Hardin, Johnson, Kenneth L Smalls, La Tasham Gunter, LCDR Matthew R Mcnew, MPH, REHS/RS, LCDR Wilfred A Darang, Lequita M Mayhew, Lori A Holmquist, Margaret H Waters, Margaret Torres Vazquez, Marion W Nadeau, Marla A Cassidy, Mary K Leslie, Merideth K Rose, Nancy L Meade, Nancy L Neiger, Normica G Facey, Patricia A Morrow, Paula J Bretz, Pelekakis, Peter R Lenahan, Philip W Beck, Randy L Clarida, Richard J Bashay, Samuel M Aboagye, Scott M Esser, Sean R Moynihan, MPH, Shavon L Square, Sherry L Secrist, BLT DO, Sierra M Shockley, Stephen C Eason, Steven D Banks, Tamara N Champion, Tamika E Allen, RN, Tania E Vizcaino, Tania Y Hall, Thomas J Hudson, Tiki J Dixon, William D Bassett, Jr

Amy C Amaro's Documents

Publish Date Document Type Title
August, 2017 FDA 483 Grifols Biomat USA Inc. - Form 483, 2017-08-31
August, 2017 EIR Grifols Biomat USA Inc. - EIR, 2017-08-31

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more